Cite
HARVARD Citation
Kayamori, K. et al. (2019). Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma. Hematology. 24 (1), pp. 52-59. [Online].